Kiski Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Kiski Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$4.65M	Buy	+70,879	New	+$4.38M	17.81%	2

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Kiski Partners's TEVA Position: Q4 2015 in Review

Kiski Partners opened a new position in Teva Pharmaceuticals (TEVA) in Q4 2015: 70,879 shares worth $4.65M. The stake represents 17.81% of the portfolio and ranks #2 among its holdings.

877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Kiski Partners held 70,879 shares of Teva Pharmaceuticals worth $4.65M as of Q4 2015.
Teva Pharmaceuticals was a new Kiski Partners position in Q4 2015.
Teva Pharmaceuticals made up 17.81% of Kiski Partners's portfolio in Q4 2015, its #2 holding.
877 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Kiski Partners's 13F filing for Q4 2015, filed 18 Feb 2016.